Overview
Legality, special rules, and flavor text
Rules
Other artifact creatures you control have haste. Whenever one or more artifact creatures you control attack, Alibou deals X damage to any target and you scry X, where X is the number of tapped artifacts you control.
Rulings
If Alibou leaves the battlefield, artifact creatures you control lose haste. If they haven't been under your control since the turn began and don't otherwise have haste, they can't attack that turn. If they've already attacked, losing haste won't remove them from combat and they'll remain attackers. — If you control no tapped artifacts when the triggered ability resolves (perhaps because they were destroyed or had vigilance), no damage will be dealt and you won't scry. — You choose a target as Alibou's triggered ability is put on the stack. If that target isn't legal as the triggered ability tries to resolve, it doesn't resolve and you don't scry.
Card details
Printing, type line, and catalog data
Identity & printing
- Card ID
- EOC-113--normal
- Name
- Alibou, Ancient Witness
- Number
- 113
- Rarity
- Mythic
Set, artist & references
- Artist
- Matt Stewart
- Language
- English
- Set name
- Edge of Eternities Commander
- Game name
- Magic: The Gathering
Battle
Abilities, attacks, weakness & resistance
Extended catalog fields
Extra Scrydex fields not shown in card details above
Raw payload (remaining)
Other game-specific keys from the API
- Supertypes
- Legendary
eBay market prices
Sold and listed medians — tap a grade for comps
More conditions (eBay)
Add LP / MP / HP / DMG or a slab grade (PSA 8, ACE 9, BGS 9.5, …). Everyone sees the same prices; scheduled refreshes include these variants.
Listed on marketplace
Vendors currently listing this card/product on our marketplace. Click through to view or purchase (purchase flow coming soon).
No marketplace listings for this card right now.
More in this set
Other cards from Edge of Eternities Commander
Comments
Share your thoughts on this card — condition, value, pull rates, etc.
to comment.
No comments yet. Be the first to share your thoughts.












